Birmingham, UK, consented their first patient in the Ver-A-T1D clinical trial. Also Bristol, Cambridge and Cardiff are now open for recruitment. 120 patients aged between 18 and ˂45 years will be included. Purpose of the study is to protect and strengthen the insulin producing beta cells and slowing down beta cell destruction in type 1 diabetes.
UK now open for Ver-A-T1D recruitment
30. July 2021